Surgical Science Sweden AB (publ), commonly referred to as Surgical Science, is a leading innovator in the field of medical simulation technology, headquartered in Sweden. Founded in 2004, the company has established itself as a key player in the surgical training industry, providing advanced simulation solutions that enhance the skills of healthcare professionals. With a strong presence in Europe and North America, Surgical Science focuses on developing high-fidelity simulators for various surgical procedures, including laparoscopic and robotic surgery. Their unique offerings, characterised by realistic haptic feedback and immersive environments, set them apart in the competitive landscape. Recognised for their commitment to quality and innovation, Surgical Science has achieved significant milestones, including partnerships with prestigious medical institutions and a growing portfolio of products that cater to the evolving needs of surgical education.
How does Surgical Science Sweden AB (publ)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Surgical Science Sweden AB (publ)'s score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Surgical Science Sweden AB (publ) currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Surgical Science Sweden AB (publ) may not have established formal commitments to reduce its carbon footprint or may not yet be participating in recognised climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the company operates within the medical technology sector, it is essential for it to consider the growing emphasis on sustainability and climate responsibility in the industry. While no specific emissions data or reduction initiatives are available, the company may still be in the process of developing its climate strategy and commitments.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Surgical Science Sweden AB (publ) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
